Ablate and pace for drug refractory paroxysmal atrial fibrillation: Is ablation necessary?

International Journal of Cardiology

Volumn 75, Issue 2-3, 2000, Pages 187-195

  Levy, T ^a   Walker, S ^a   Rex, S ^a   Paul, V ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Ablation; Pacing; Paroxysmal atrial fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACEMAKER; HEART ATRIUM PACING; HOLTER MONITORING; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SELF REPORT; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 0034664915     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(00)00322-3     Document Type: Article

References (34)

1. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: Impact of treatment in paroxysmal and established atrial fibrillation
2. Improvement in left ventricular function by ablatio of atrioventricular nodal conduction in selected patients with atrial fibrillation
3. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation
4. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug refractory atrial arrhythmias
5. Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation
6. Quality of life in patients with complete heart block and paroxysmal atrial tachyarrhythmias: A comparison of permanent DDIR versus DDDR pacing with mode switch to DDIR
7. Is mode switching beneficial? A randomised study in patients with paroxysmal atrial tachyarrhythmias
8. Assessment of atrioventricular junction ablation and DDDR mode switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation. A randomised controlled study
9. Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: Effective treatment for drug refractory paroxysmal atrial fibrillation
10. Prospective randomised study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation. Effects of pacing mode and mode-switch algorithm
11. Control of rapid heart rates in patients with atrial fibrillation: Drugs or ablation?
12. Mitral valve replacement for pacing-induced severe mitral regurgitation after radiofrequency ablation of the atrioventricular node
13. Haemodynamic deterioration following radiofrequency ablation of the atrioventricular conduction system
14. Pacemaker induced Mitral Regurgitation: An alternative form of pacemaker syndrome
15. Long-term effect of right ventricular pacing on myocardial perfusion and function
16. Ablate and pace therapy for paroxysmal atrial fibrillation, too much too late
17. Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: Effective treatment for drug refractory paroxysmal atrial fibrillation
18. Evaluation of bi-atrial pacing, Right atrial pacing and no pacing, in patients with drug refractory atrial fibrillation
19. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive
20. How to evaluate quality of life in pacemaker patients: Problems and pitfalls
21. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation
22. For the PA3 investigators. Declining AV junction ablation for paroxysmal atrial fibrillation is associated with pacing in the atrium and improved quality of life in the PA3 trial
23. For the PA3 investigators. Atrial pacing peri-ablation for paroxysmal atrial fibrillation-phase 1
24. Impact of atrial pacing in patients with paroxysmal atnial fibrillation and no standard indication for pacing: Ambulatory monitoring analysis from the PA3 trial
25. Ablate and pace: A pragmatic approach to paroxysmal atrial fibrillation not controlled by antiarrhythmic drugs
26. Atrial rhythm after atrioventricular junctional ablation
27. Predictors of atrial rhythm after atrioventricular none ablation for the treatment of paroxysmal atrial arrhythmias
28. Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias
29. High atrial pressure directly affects the dispersion of refractoriness and the inducibility of atrial fibrillation
30. The effects of atrial dilatation on the genesis of atrial arrhythmias
31. Effect of atrioventricular interval during pacing or reciprocating tachycardia on atrial size, pressure, and refractory period. Contraction-excitation feedback in human atrium
32. Does AV nodal ablation impair long-term survival compared with medical treatment of atrial fibrillation?
33. Pacing in hypertrophic obstructive cardiomyopathy. A randomised crossover study. PIC study group
34. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomised, double blind, crossover trial